-
1
-
-
0037047030
-
Anticoagulants and antiplatelet agents in acute ischemic stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association)
-
Coull, B.M., Williams, L.S., Goldstein, L.B. et al. Anticoagulants and antiplatelet agents in acute ischemic stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Neurology 2002, 59: 13-22.
-
(2002)
Neurology
, vol.59
, pp. 13-22
-
-
Coull, B.M.1
Williams, L.S.2
Goldstein, L.B.3
-
2
-
-
0034330788
-
Thrombolytic, antithrombin, and antiplatelet treatment of acute coronary syndromes
-
Puma, J.A. and Sketch, M.H. Jr. Thrombolytic, antithrombin, and antiplatelet treatment of acute coronary syndromes. J Am Osteopath Assoc 2000, 100(11 Suppl): S8-12.
-
(2000)
J Am Osteopath Assoc
, vol.100
, Issue.11 SUPPL.
-
-
Puma, J.A.1
Sketch Jr., M.H.2
-
3
-
-
0036383723
-
New targets for antithrombotic drugs
-
Thiagarajan, P. New targets for antithrombotic drugs. Am J Cardiovasc Drugs 2002, 2: 227-35.
-
(2002)
Am J Cardiovasc Drugs
, vol.2
, pp. 227-235
-
-
Thiagarajan, P.1
-
4
-
-
0028324464
-
Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium-and phospholipid-binding proteins
-
Raynal, P. and Pollard, H.B. Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium-and phospholipid-binding proteins. Biochim Biophys Acta 1994, 1197: 63-93.
-
(1994)
Biochim Biophys Acta
, vol.1197
, pp. 63-93
-
-
Raynal, P.1
Pollard, H.B.2
-
5
-
-
20344369564
-
Annexins: Linking Ca2+ signalling to membrane dynamics
-
Gerke, V., Creutz, C.E. and Moss, S.E. Annexins: Linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005, 6: 449-61.
-
(2005)
Nat Rev Mol Cell Biol
, vol.6
, pp. 449-461
-
-
Gerke, V.1
Creutz, C.E.2
Moss, S.E.3
-
6
-
-
0025824602
-
Chromosomal localization of the human gene for annexin V (placental anticoagulant protein I) to 4q26 - q28
-
Tait, J.F., Frankenberry, D.A., Shiang, R. et al. Chromosomal localization of the human gene for annexin V (placental anticoagulant protein I) to 4q26 - q28. Cytogenet Cell Genet 1991, 57: 187-92.
-
(1991)
Cytogenet Cell Genet
, vol.57
, pp. 187-192
-
-
Tait, J.F.1
Frankenberry, D.A.2
Shiang, R.3
-
7
-
-
0037105378
-
A common polymorphism in the annexin V Kozak sequence (-IC>T) increases translation efficiency and plasma levels of annexin V and decreases the risk of myocardial infarction in young patients
-
Gonzalez-Conejero, R., Corral, J., Roldan, V. et al. A common polymorphism in the annexin V Kozak sequence (-IC>T) increases translation efficiency and plasma levels of annexin V and decreases the risk of myocardial infarction in young patients. Blood 2002, 100: 2081-6.
-
(2002)
Blood
, vol.100
, pp. 2081-2086
-
-
Gonzalez-Conejero, R.1
Corral, J.2
Roldan, V.3
-
8
-
-
0034256979
-
Measurement of urinary annexin V by ELISA and its significance as a new urinary-marker of kidney disease
-
Matsuda, R., Kaneko, N., Horikawa, Y. et al. Measurement of urinary annexin V by ELISA and its significance as a new urinary-marker of kidney disease. Clin Chim Acta 2000, 298: 29-43.
-
(2000)
Clin Chim Acta
, vol.298
, pp. 29-43
-
-
Matsuda, R.1
Kaneko, N.2
Horikawa, Y.3
-
9
-
-
0032730110
-
Decreased concentration of annexin V in parkinsonian cerebrospinal fluid: Speculation on the underlying cause
-
Vermes, I., Steur, E.N., Reutelingsperger, C. et al. Decreased concentration of annexin V in parkinsonian cerebrospinal fluid: Speculation on the underlying cause. Mov Disord 1999, 14: 1008-10.
-
(1999)
Mov Disord
, vol.14
, pp. 1008-1010
-
-
Vermes, I.1
Steur, E.N.2
Reutelingsperger, C.3
-
10
-
-
0025000276
-
The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes
-
Huber, R., Romisch, J. and Paques, E.P. The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes. EMBO J 1990, 9: 3867-74.
-
(1990)
EMBO J
, vol.9
, pp. 3867-3874
-
-
Huber, R.1
Romisch, J.2
Paques, E.P.3
-
11
-
-
0022387184
-
Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord
-
Reutelingsperger, C.P., Hornstra, G. and Hemker, H.C. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur J Biochem 1985, 151: 625-9.
-
(1985)
Eur J Biochem
, vol.151
, pp. 625-629
-
-
Reutelingsperger, C.P.1
Hornstra, G.2
Hemker, H.C.3
-
12
-
-
0023175021
-
Human placental anticoagulant protein: Isolation and characterization
-
Funakoshi, T., Heimark, R.L., Hendrickson, L.E. et al. Human placental anticoagulant protein: Isolation and characterization. Biochemistry 1987, 26: 5572-8.
-
(1987)
Biochemistry
, vol.26
, pp. 5572-5578
-
-
Funakoshi, T.1
Heimark, R.L.2
Hendrickson, L.E.3
-
13
-
-
0001110232
-
Annexin V is critical in the maintenance of murine placental integrity
-
Wang, X., Campos, B., Kaetzel, M.A. et al. Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynecol 1999, 180: 1008-16.
-
(1999)
Am J Obstet Gynecol
, vol.180
, pp. 1008-1016
-
-
Wang, X.1
Campos, B.2
Kaetzel, M.A.3
-
14
-
-
29544437912
-
Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses
-
Rand, J.H., Arslan, A.A., Wu, X.X. et al. Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses. Am J Obstet Gynecol 2006, 194: 182-8.
-
(2006)
Am J Obstet Gynecol
, vol.194
, pp. 182-188
-
-
Rand, J.H.1
Arslan, A.A.2
Wu, X.X.3
-
15
-
-
0037385228
-
Annexin A5 is not essential for skeletal development
-
Brachvogel, B., Dikschas, J., Moch, H. et al. Annexin A5 is not essential for skeletal development. Mol Cell Biol 2003, 23: 2907-13.
-
(2003)
Mol Cell Biol
, vol.23
, pp. 2907-2913
-
-
Brachvogel, B.1
Dikschas, J.2
Moch, H.3
-
16
-
-
1842678190
-
Remodeling the blood coagulation cascade
-
Hoffman, M. Remodeling the blood coagulation cascade. J Thromb Thrombolysis 2003, 16: 17-20.
-
(2003)
J Thromb Thrombolysis
, vol.16
, pp. 17-20
-
-
Hoffman, M.1
-
17
-
-
0037567421
-
Exposure of platelet membrane phosphatidylserine regulates blood coagulation
-
Lentz, B.R. Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res 2003, 42: 423-38.
-
(2003)
Prog Lipid Res
, vol.42
, pp. 423-438
-
-
Lentz, B.R.1
-
18
-
-
0027978049
-
Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar head-group of phosphatidylserine
-
Comfurius, P., Smeets, E.F., Willems, G.M. et al. Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar head-group of phosphatidylserine. Biochemistry 1994, 33: 10319-24.
-
(1994)
Biochemistry
, vol.33
, pp. 10319-10324
-
-
Comfurius, P.1
Smeets, E.F.2
Willems, G.M.3
-
19
-
-
5644234913
-
Tissue factor: (Patho)physiology and cellular biology
-
Eilertsen, K.E. and Osterud, B. Tissue factor: (Patho)physiology and cellular biology. Blood Coagul Fibrinolysis 2004, 15: 521-38.
-
(2004)
Blood Coagul Fibrinolysis
, vol.15
, pp. 521-538
-
-
Eilertsen, K.E.1
Osterud, B.2
-
20
-
-
0026666704
-
Phospholipid binding of annexin V: Effects of calcium and membrane phosphatidylserine content
-
Tait, J.F. and Gibson, D. Phospholipid binding of annexin V: Effects of calcium and membrane phosphatidylserine content. Arch Biochem Biophys 1992, 298: 187-91.
-
(1992)
Arch Biochem Biophys
, vol.298
, pp. 187-191
-
-
Tait, J.F.1
Gibson, D.2
-
21
-
-
0026744185
-
Clustering of lipid-bound annexin V may explain its anticoagulant effect
-
Andree, H.A., Stuart, M.C., Hermens, W.T. et al. Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem 1992, 267: 17907-12.
-
(1992)
J Biol Chem
, vol.267
, pp. 17907-17912
-
-
Andree, H.A.1
Stuart, M.C.2
Hermens, W.T.3
-
22
-
-
14044277623
-
Annexin A5 down-regulates surface expression of tissue factor: A novel mechanism of regulating the membrane receptor repertoir
-
Ravassa, S., Bennaghmouch, A., Kenis, H. et al. Annexin A5 down-regulates surface expression of tissue factor: A novel mechanism of regulating the membrane receptor repertoir. J Biol Chem 2005, 280: 6028-35.
-
(2005)
J Biol Chem
, vol.280
, pp. 6028-6035
-
-
Ravassa, S.1
Bennaghmouch, A.2
Kenis, H.3
-
23
-
-
3042800376
-
Human annexin V binds to sulfatide: Contribution to regulation of blood coagulation
-
Ida, M., Satoh, A., Matsumoto, I. et al. Human annexin V binds to sulfatide: contribution to regulation of blood coagulation. J Biochem, Tokyo 2004, 135: 583-8.
-
(2004)
J Biochem, Tokyo
, vol.135
, pp. 583-588
-
-
Ida, M.1
Satoh, A.2
Matsumoto, I.3
-
24
-
-
0033026762
-
Interaction of heparin with annexin V
-
Capila, I., VanderNoot, V.A., Mealy, T.R. et al. Interaction of heparin with annexin V FEBS Lett 1999, 446: 327-30.
-
(1999)
FEBS Lett
, vol.446
, pp. 327-330
-
-
Capila, I.1
VanderNoot, V.A.2
Mealy, T.R.3
-
25
-
-
0028133089
-
A new function of calphobindin 1 (annexin V). Promotion of both migration and urokinase-type plasminogen activator activity of normal human keralinocytes
-
Nakao, H., Watanabe, M., Maki, M. A new function of calphobindin 1 (annexin V). Promotion of both migration and urokinase-type plasminogen activator activity of normal human keralinocytes. Eur J Biochem 1994, 223: 901-8.
-
(1994)
Eur J Biochem
, vol.223
, pp. 901-908
-
-
Nakao, H.1
Watanabe, M.2
Maki, M.3
-
26
-
-
33747052567
-
Antithrombotic action of annexin V proved as efficient as direct inhibition of tissue factor or thrombin
-
Galan, A.M. van Heerde, W.L., Escolar, G. et al. Antithrombotic action of annexin V proved as efficient as direct inhibition of tissue factor or thrombin. Eur J Clin Invest 2006, 36: 633-9.
-
(2006)
Eur J Clin Invest
, vol.36
, pp. 633-639
-
-
Galan, A.M.1
van Heerde, W.L.2
Escolar, G.3
-
27
-
-
23944509766
-
Tissue factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation
-
Del Conde, I., Shrimpton, C.N., Thiagarajan, P. et al. Tissue factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005, 106: 1604-11.
-
(2005)
Blood
, vol.106
, pp. 1604-1611
-
-
Del Conde, I.1
Shrimpton, C.N.2
Thiagarajan, P.3
-
28
-
-
18544388401
-
Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants
-
Chen, H.H., Vicente, C.P., He, L. et al. Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants. Blood 2005, 105: 3902-9.
-
(2005)
Blood
, vol.105
, pp. 3902-3909
-
-
Chen, H.H.1
Vicente, C.P.2
He, L.3
-
29
-
-
28044436486
-
A study of human annexin V derivative: Its effects of anticoagulation and antithrombosis.]
-
Ju, C.W., Wang, L.S., Yang, X. et al. [A study of human annexin V derivative: Its effects of anticoagulation and antithrombosis.]. Zhonghua Xue Ye Xue Za Zhi 2004, 25: 540-3.
-
(2004)
Zhonghua Xue Ye Xue Za Zhi
, vol.25
, pp. 540-543
-
-
Ju, C.W.1
Wang, L.S.2
Yang, X.3
-
30
-
-
31544434253
-
A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties
-
Huang, X., Ding, W.Q., Vaught, J.L. et al. A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties. Blood 2006, 107: 980-6.
-
(2006)
Blood
, vol.107
, pp. 980-986
-
-
Huang, X.1
Ding, W.Q.2
Vaught, J.L.3
-
31
-
-
0027989808
-
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis
-
Koopman, G., Reutelingsperger, C.P., Kuijten, G.A. et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994, 84: 1415-20.
-
(1994)
Blood
, vol.84
, pp. 1415-1420
-
-
Koopman, G.1
Reutelingsperger, C.P.2
Kuijten, G.A.3
-
32
-
-
33644876123
-
Past, present, and future of annexin A5: From protein discovery to clinical applications
-
Boersma, H.H., Kietselaer, B.L., Stolk, L.M. et al. Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med 2005, 46: 2035-50.
-
(2005)
J Nucl Med
, vol.46
, pp. 2035-2050
-
-
Boersma, H.H.1
Kietselaer, B.L.2
Stolk, L.M.3
-
33
-
-
17644412023
-
Inflammation, atherosclerosis, and coronary artery disease
-
Hansson, G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352: 1685-95.
-
(2005)
N Engl J Med
, vol.352
, pp. 1685-1695
-
-
Hansson, G.K.1
-
34
-
-
0032693599
-
Atherosclerosis is an inflammatory disease
-
Ross, R. Atherosclerosis is an inflammatory disease. Am Heart J 1999, 138(5 Pt 2): S419-20.
-
(1999)
Am Heart J
, vol.138
, Issue.5 PART 2
-
-
Ross, R.1
-
35
-
-
0038683379
-
Coagulation and inflammation
-
Esmon, C.T. Coagulation and inflammation. J Endotoxin Res 2003, 9: 192-8.
-
(2003)
J Endotoxin Res
, vol.9
, pp. 192-198
-
-
Esmon, C.T.1
-
36
-
-
1842662594
-
The vulnerable atherosclerotic plaque: Pathogenesis and therapeutic approach
-
Aikawa, M. and Libby, P. The vulnerable atherosclerotic plaque: Pathogenesis and therapeutic approach. Cardiovasc Pathol 2004, 13: 125-38.
-
(2004)
Cardiovasc Pathol
, vol.13
, pp. 125-138
-
-
Aikawa, M.1
Libby, P.2
-
37
-
-
0037097706
-
Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque
-
Ananyeva, N.M., Kouiavskaia, D.V., Shima, M. et al. Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque. Blood 2002, 99: 4475-85.
-
(2002)
Blood
, vol.99
, pp. 4475-4485
-
-
Ananyeva, N.M.1
Kouiavskaia, D.V.2
Shima, M.3
-
38
-
-
16944365813
-
Tissue factor modulates the thrombogenicity of human atherosclerotic plaques
-
Toschi, V., Gallo, R., Lettino, M. et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997, 95: 594-9.
-
(1997)
Circulation
, vol.95
, pp. 594-599
-
-
Toschi, V.1
Gallo, R.2
Lettino, M.3
-
39
-
-
0001495165
-
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
-
Wilcox, J.N., Smith, K.M., Schwartz, S.M. et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 1989, 86: 2839-43.
-
(1989)
Proc Natl Acad Sci U S A
, vol.86
, pp. 2839-2843
-
-
Wilcox, J.N.1
Smith, K.M.2
Schwartz, S.M.3
-
40
-
-
11144229526
-
Decreased binding of annexin v to endothelial cells: A potential mechanism in atherothrombosis of patients with systemic lupus erythematosus
-
Cederholm, A., Svenungsson, E., Jensen-Urstad, K. et al. Decreased binding of annexin v to endothelial cells: A potential mechanism in atherothrombosis of patients with systemic lupus erythematosus. Arterioscler Thromb Vasc Biol 2005, 25: 198-203.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 198-203
-
-
Cederholm, A.1
Svenungsson, E.2
Jensen-Urstad, K.3
-
41
-
-
0031849291
-
The role of phosphatidylserine in recognition of apoptotic cells by phagocytes
-
Fadok, V.A., Bratton, D.L., Frasch, S.C. et al. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ 1998, 5: 551-62.
-
(1998)
Cell Death Differ
, vol.5
, pp. 551-562
-
-
Fadok, V.A.1
Bratton, D.L.2
Frasch, S.C.3
-
42
-
-
33644925825
-
Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches
-
Kenis, H., van Genderen, H., Deckers, N.M. et al. Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches. Exp Cell Res 2006, 312: 719-26.
-
(2006)
Exp Cell Res
, vol.312
, pp. 719-726
-
-
Kenis, H.1
van Genderen, H.2
Deckers, N.M.3
-
44
-
-
0033778724
-
Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice
-
Stach, C.M., Turnay, X., Voll, R.E. et al. Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice. Cell Death Differ 2000, 7: 911-5.
-
(2000)
Cell Death Differ
, vol.7
, pp. 911-915
-
-
Stach, C.M.1
Turnay, X.2
Voll, R.E.3
-
45
-
-
0027477081
-
The effects of heparin and annexin V on fibrin accretion after injury in the jugular veins of rabbits
-
Van Ryn-McKenna, J., Merk, H., Muller, T.H. et al. The effects of heparin and annexin V on fibrin accretion after injury in the jugular veins of rabbits. Thromb Haemost 1993, 69: 227-30.
-
(1993)
Thromb Haemost
, vol.69
, pp. 227-230
-
-
Van Ryn-McKenna, J.1
Merk, H.2
Muller, T.H.3
-
46
-
-
0030819147
-
Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model
-
Thiagarajan, P. and Benedict, C.R. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. Circulation 1997, 96: 2339-47.
-
(1997)
Circulation
, vol.96
, pp. 2339-2347
-
-
Thiagarajan, P.1
Benedict, C.R.2
-
47
-
-
33747393705
-
99mTc-annexin-V functional imaging of luminal thrombus activity in abdominal aortic aneurysms
-
Sarda-Mantel, L., Coutard, M., Rouzet, F. et al. 99mTc-annexin-V functional imaging of luminal thrombus activity in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006, 26: 2153-9.
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 2153-2159
-
-
Sarda-Mantel, L.1
Coutard, M.2
Rouzet, F.3
-
48
-
-
24144438580
-
Atherosclerosis in patients with autoimmune disorders
-
Frostegard, J. Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol 2005, 25: 1776-85.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 1776-1785
-
-
Frostegard, J.1
-
49
-
-
32644443487
-
Accelerated atherosclerosis in autoimmune rheumatic diseases
-
Shoenfeld, Y., Gerli, R., Doria, A. et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005, 112: 3337-47.
-
(2005)
Circulation
, vol.112
, pp. 3337-3347
-
-
Shoenfeld, Y.1
Gerli, R.2
Doria, A.3
-
50
-
-
0034884321
-
beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: The honolulu heart program
-
Brey, R.L., Abbott, R.D., Curb, J.D. et al. beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: The honolulu heart program. Stroke 2001, 32: 1701-6.
-
(2001)
Stroke
, vol.32
, pp. 1701-1706
-
-
Brey, R.L.1
Abbott, R.D.2
Curb, J.D.3
-
51
-
-
0035899949
-
Risk factors for cardiovascular disease in systemic lupus erythematosus
-
Svenungsson, E., Jensen-Urstad, K., Heimburger, M. et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001, 104: 1887-93.
-
(2001)
Circulation
, vol.104
, pp. 1887-1893
-
-
Svenungsson, E.1
Jensen-Urstad, K.2
Heimburger, M.3
-
52
-
-
0017295808
-
The bimodal mortality pattern of systemic lupus erythematosus
-
Urowitz, M.B., Bookman, A.A., Koehler, B.E. et al. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976, 60: 221-5.
-
(1976)
Am J Med
, vol.60
, pp. 221-225
-
-
Urowitz, M.B.1
Bookman, A.A.2
Koehler, B.E.3
-
53
-
-
0031052874
-
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study
-
Mar 1
-
Manzi, S., Meilahn, E.N., Rairie, J.E. et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study. Am J Epidemiol Mar 1 1997, 145: 408-15.
-
(1997)
Am J Epidemiol
, vol.145
, pp. 408-415
-
-
Manzi, S.1
Meilahn, E.N.2
Rairie, J.E.3
-
54
-
-
0035050697
-
Vascular stiffness in women with systemic lupus erythematosus
-
Selzer, F., Sutton-Tyrrell, K., Fitzgerald, S. et al. Vascular stiffness in women with systemic lupus erythematosus. Hypertension 2001, 37: 1075-82.
-
(2001)
Hypertension
, vol.37
, pp. 1075-1082
-
-
Selzer, F.1
Sutton-Tyrrell, K.2
Fitzgerald, S.3
-
55
-
-
7244254348
-
Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome
-
Rand, J.H., Wu, X.X., Lapinski, R. et al. Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome. Blood 2004, 104: 2783-90.
-
(2004)
Blood
, vol.104
, pp. 2783-2790
-
-
Rand, J.H.1
Wu, X.X.2
Lapinski, R.3
-
56
-
-
0042694704
-
Inhibition of annexin V binding to cardiolipin and thrombin generation in an unselected population with venous thrombosis
-
Hanly, J.G., Smith, S.A. and Anderson, D. Inhibition of annexin V binding to cardiolipin and thrombin generation in an unselected population with venous thrombosis. J Rheumatol 2003, 30: 1990-3.
-
(2003)
J Rheumatol
, vol.30
, pp. 1990-1993
-
-
Hanly, J.G.1
Smith, S.A.2
Anderson, D.3
-
57
-
-
0030715044
-
Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi
-
Rand, J.H., Wu, X.X., Guller, S. et al. Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. Am J Obstet Gynecol 1997, 177: 918-23.
-
(1997)
Am J Obstet Gynecol
, vol.177
, pp. 918-923
-
-
Rand, J.H.1
Wu, X.X.2
Guller, S.3
-
58
-
-
10844288801
-
TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss
-
Berman, J., Girardi, G. and Salmon, J.E. TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss. J Immunol 2005, 174: 485-90.
-
(2005)
J Immunol
, vol.174
, pp. 485-490
-
-
Berman, J.1
Girardi, G.2
Salmon, J.E.3
-
59
-
-
0037148520
-
Complement C3 activation is required for antiphospholipid antibody-induced fetal loss
-
Holers, V.M., Girardi, G., Mo, L. et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002, 195: 211-20.
-
(2002)
J Exp Med
, vol.195
, pp. 211-220
-
-
Holers, V.M.1
Girardi, G.2
Mo, L.3
-
60
-
-
16244407441
-
C-reactive protein and annexin A5 bind to distinct sites of negatively charged phospholipids present in oxidized low-density lipoprotein
-
van Tits, L., de Graaf, J., Toenhake, H. et al. C-reactive protein and annexin A5 bind to distinct sites of negatively charged phospholipids present in oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol 2005, 25: 717-22.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 717-722
-
-
van Tits, L.1
de Graaf, J.2
Toenhake, H.3
-
61
-
-
33646467929
-
Annexin V associates with the IFN-gamma receptor and regulates IFN-gamma signaling
-
Leon, C., Nandan, D., Lopez, M. et al. Annexin V associates with the IFN-gamma receptor and regulates IFN-gamma signaling. J Immunol 2006, 176: 5934-42.
-
(2006)
J Immunol
, vol.176
, pp. 5934-5942
-
-
Leon, C.1
Nandan, D.2
Lopez, M.3
|